Esketamine for Adolescents with Depression

A groundbreaking study Presented at the 2023 Annual Meeting of the American Psychiatric Association San Francisco, CA, demonstrates that esketamine nasal spray can rapidly reduce depressive symptoms in adolescents at high risk of suicide.

Unlike previous antidepressant trials, this study includes a vulnerable patient population that has been traditionally overlooked: adolescents at immediate and imminent risk of suicide. These findings contribute to our understanding of the potential benefits of esketamine and highlight the importance of inclusivity in clinical trials to address the needs of all patient groups. This study was conducted on male or female teenagers between the ages of 12 and 18 who had been diagnosed with Major Depressive Disorder.

The results of this study revealed a meaningful improvement in depressive symptoms, which was both statistically and clinically significant, observed just 24 hours after the initial administration of pooled Esketamine doses at 56 mg and 84 mg. In comparison to a psychoactive comparator, the use of esketamine demonstrated a clear advantage in alleviating depressive symptoms. Treatment with a psychological intervention (individual cognitive behavioral therapy, interpersonal therapy, family

therapy, psychodynamic psychotherapy) was also required, at least through the initial 8-week Post-Treatment Follow-Up phase.

These findings provide substantial evidence supporting the efficacy of esketamine as a potential treatment option for individuals struggling with depression. By showcasing its rapid action and significant impact, this study contributes to our understanding of the therapeutic potential of esketamine and highlights its superiority over existing psychoactive comparators.

This study indicated that the adolescents experienced a rapid decrease in depressive symptoms, which aligns with similar findings observed in phase 3 studies involving adults with Major Depressive Disorder (MDD) who were dealing with acute suicidal thoughts or behavior. It is noteworthy that there were no new or unexpected safety concerns identified in the adolescent participants, and these observations were consistent with previous trials conducted with adults at risk of suicide.

These conclusions provide further evidence supporting the effectiveness and safety of the treatment across different age groups, highlighting its potential as a valuable intervention in addressing depression and reducing the risk of suicide in both adolescents and adults with MDD.

Here at Blue Umbrella, we proudly offer Spravato (EsKetamine) as a form of treatment for suicidal ideation. We have seen tremendous improvement in multiple dire cases and are excited to share this innovative and effective treatment option with the community.

References:

Colette Kosik-Gonzalez

MA1

Dong Jing Fu

MD, PhD1*

Li "Nancy" Chen

PhD1

Rosanne Lane

MAS1

Wayne C. Drevets

MD2

Carla M. Canuso

MD1

Janssen Research and Development, LLC

Titusville, NJ | San Diego, CA

Esketamine Nasal Spray versus Psychoactive Comparator for Rapid Reduction of Depressive Symptoms in adolescents at Imminent Suicide Risk, 2023

< Older Post

Newer Post >

Spring Cleaning for Your Mind and Mood: Refresh Your Mental Health

April 1, 2026

Spring is a time of renewal — flowers bloom, days get longer, and energy is in the air. While many people think of spring cleaning as decluttering closets and dusting shelves, your mind and mood can benefit from a little seasonal refresh too. At Blue Umbrella Psychiatry, we help patients clear mental clutter, reset routines, and create space for focus, calm, and emotional balance — using both therapy and psychiatric care.

Navigating Stress in Uncertain Times: Mental Health Tips

March 26, 2026

Spring is officially here, and with it comes a mix of renewal, change, and — for many — stress. Whether it’s adjusting to the end of tax season, following local or global news, or managing transitions in work and school, current events can impact mental well-being in subtle and not-so-subtle ways. At Blue Umbrella Psychiatry , we know that external stressors affect everyone differently. Some people feel mild tension, while others experience anxiety, sleep disruption, or a sense of being “stuck” despite otherwise stable circumstances.

When Talking Isn’t Enough: Understanding EMDR and the Power of Therapy

March 19, 2026

Not all wounds are visible. Some experiences stay stored in the body — surfacing as anxiety, triggers, panic, emotional numbness, or patterns that feel difficult to break. You may understand logically that something is “in the past,” yet your nervous system still reacts as if it’s happening now. This is where therapy — and specifically EMDR — can make a meaningful difference. At Blue Umbrella Psychiatry , we have six therapists with diverse specialties, availability, and insurance participation. Among them, we are proud to offer EMDR therapy for individuals seeking a focused, trauma-informed approach to healing.

TMS Therapy: A Non-Medication Approach for Depression, OCD, and Adolescents

March 12, 2026

Mental health treatment has evolved significantly over the past decade. While therapy and medication remain foundational tools, advances in neuroscience have created additional options for individuals who need something different. One of the most established and research-supported of these options is Transcranial Magnetic Stimulation (TMS). At Blue Umbrella Psychiatry , we provide TMS therapy for adults with treatment-resistant depression, individuals with OCD, and adolescents with depression — and in many cases, treatment may be covered by insurance.

When Traditional Treatments Aren’t Enough: A New Approach with Ketamine Therapy

March 5, 2026

You’ve tried therapy. You’ve tried medication. You’ve given it time. And yet, something still feels heavy. For many individuals struggling with depression, anxiety, mood instability, or persistent symptoms, the path to feeling better is not always linear. When traditional antidepressants or therapy alone haven’t provided enough relief, it does not mean you have failed treatment. It may mean your brain needs a different approach. At Blue Umbrella Psychiatry , we now offer ketamine therapy in three forms: IV, IM, and in-clinic oral administration , allowing for personalized care based on clinical needs and patient comfort.

High-Functioning Anxiety: When You Look Fine but Feel Exhausted

February 26, 2026

From the outside, everything looks good. You show up to work. You meet deadlines. You’re reliable, organized, and productive. People might even describe you as “on top of things.” But inside, it’s a different story. Your mind rarely slows down. You’re constantly anticipating problems, replaying conversations, or mentally running through to-do lists. Rest doesn’t feel restorative. Even on “good” days, there’s a persistent sense of tension, pressure, or exhaustion. This is often what high-functioning anxiety looks like—and it’s more common than many people realize.

Sleep Problems and Mental Health: What’s the Connection?

February 19, 2026

Most of us have had a rough night of sleep and felt the effects the next day—irritable, foggy, unfocused, or emotionally sensitive. But when sleep problems become ongoing, they can affect much more than just energy levels. There’s a strong, two-way relationship between sleep and mental health, and understanding that connection is an important step toward feeling better. At Blue Umbrella Psychiatry, we often see how closely sleep and emotional well-being are intertwined. Let’s take a closer look at why sleep matters so much for mental health—and what to do when it’s not going well.